Magnesium, Little Known But Possibly Relevant: A Link between NASH and Related Comorbidities

• Published in: Biomedicines Vol. 9; no. 2; p. 125
• Main Authors: Simón, Jorge, Delgado, Teresa Cardoso, Martinez-Cruz, Luis Alfonso, Martínez-Chantar, Maria Luz
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 27.01.2021; MDPI
• Subjects: Cancer; Cardiovascular diseases; Cell cycle; Diabetes; Diabetes mellitus (non-insulin dependent); Dietary supplements; Fatty acids; Homeostasis; Hypertension; Hypomagnesemia; Inflammation; Insulin; Insulin resistance; insulin resistance (IR); Kinases; Lipids; Liver diseases; Magnesium; magnesium (Mg2+); Metabolism; Mortality; non-alcoholic steatohepatitis (NASH); Obesity; Overweight; Population; Proteins; Public health; Review; type 2 diabetes mellitus (T2DM); Womens health; United States > US; magnesium (Mg2+); cardiovascular diseases (CVD); non-alcoholic steatohepatitis (NASH); insulin resistance (IR); hypertension; obesity; type 2 diabetes mellitus (T2DM)
• ISSN: 2227-9059; 2227-9059
• DOI: 10.3390/biomedicines9020125

Non-alcoholic steatohepatitis (NASH) is characterized by an abnormal hepatic lipid accumulation accompanied by a necro-inflammatory process and a fibrotic response. It comprises from 10% to 30% of cases of patients with non-alcoholic liver disease, which is a global health problem affecting around a quarter of the worldwide population. Nevertheless, the development of NASH is often surrounded by a pathological context with other comorbidities, such as cardiovascular diseases, obesity, insulin resistance or type 2 diabetes mellitus. Dietary imbalances are increasingly recognized as the root cause of these NASH-related comorbidities. In this context, a growing concern exists about whether magnesium consumption in the general population is sufficient. Hypomagnesemia is a hallmark of the aforementioned NASH comorbidities, and deficiencies in magnesium are also widely related to the triggering of complications that aggravate NASH or derived pathologies. Moreover, the supplementation of this cation has proved to reduce mortality from hepatic complications. In the present review, the role of magnesium in NASH and related comorbidities has been characterized, unraveling the relevance of maintaining the homeostasis of this cation for the correct functioning of the organism.